In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.
Did you know that your browser is out of date? To get the best experience using our website we recommend that you upgrade to a newer version. Learn more.

Looking into the future of echocardiography


Prof Michael Picard.jpg

Prof. Michael Picard

Professor Michael Picard is the Emeritus Director of the Echocardiography Laboratory at Massachusetts General Hospital (MGH) and Professor of Medicine at Harvard Medical School, Boston, MA, USA. He currently serves as the Editor-in-Chief of the Journal of the American Society of Echocardiography. Today, he will give the EuroEcho Lecture entitled: “Expanding Frontiers of Echocardiography.”

Prof. Picard is very well qualified to speak on this topic. In addition to his current roles, he is a Past-President of the American Society of Echocardiography (ASE) and Past-Vice President of the National Board of Echocardiography. He has been a member of numerous writing committees developing appropriateness and diagnostic criteria in the fields of transthoracic and transoesophageal echocardiography, multimodality cardiac imaging in heart failure and arrhythmogenic right ventricular cardiomyopathy/dysplasia (ARVC/D). He has served on the steering committees of several National Heart, Lung and Blood Institute grants including the SHOCK and ISCHEMIA trials and the Task Force on ARVC/D. His awards include the American College of Cardiology’s Young Investigator Award and ASE’s Richard Popp Award for Excellence in Teaching. When asked about the main highlights of his career so far, Prof. Picard said, “The most satisfying part has been mentoring over 75 echocardiography fellows at the MGH—I am proud that many of these have gone on to leadership positions within cardiology.”

Prof. Picard’s own research interests include the applications of echocardiography in coronary artery disease, translational cardiology and valvular heart disease. This work has included the integration of genetically modified small animals and novel ultrasound techniques to determine the molecular pathways that exert control over left ventricular remodelling.

About his EuroEcho Lecture, Prof. Picard explained, “There are now many other techniques besides echocardiography that can image the heart noninvasively, but echocardiography still has a unique role in clinical cardiology and research. In my lecture, I will take a quick look at where we have been with echocardiography but will mainly focus on looking into the future.”

“Other techniques are available, but echocardiography still has a unique place and we should remain very excited about what it can do now and in years to come.”

“I will discuss the role of echocardiography in personalised medicine and how genetic information combined with imaging

can be used to guide patients’ treatment.

I will mention the potential role of artificial intelligence in echocardiography and where that may lead us. I will also talk about new miniaturised echocardiography devices that are shaking up the field and causing us to rethink how we practise. Another interesting application involves new measurement techniques that may allow us to delve deeper into the identification of heart disease at subclinical stages to permit earlier treatment or prevention.” Prof. Picard said, “I am truly honoured to be invited by the EACVI to give the EuroEcho Lecture and to have the opportunity to discuss my thoughts on these new frontiers.”